Clues to quality of journals
Open Access Policy of Helmholtz Association 2016
CC Licencences
Publication Metrics
Home
Deutsch
New EVA Application
Advanced Search
Browse by ...
Publication overview
Statistics (last 5 years)
OA Publications
Submit Publication
Import publication from...
Report missing publication
Contact persons
Help
Text
Endnote (RIS)
BibTeX
Publ. Version/Full Text
DOI
PMC
 |
Closed |
Open Access Green as soon as Postprint is submitted to ZB.
Third generation PCSK9-Inhibitors.
Eur. Heart J. 44, 4281-4283 (2023)
Scopus
Cited By
Cited By
Altmetric
1
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Editorial
Keywords
Subtilisin/kexin Type 9; Reduction; Lib003; Safety
Language
english
Publication Year
2023
HGF-reported in Year
2023
ISSN (print) / ISBN
0195-668X
e-ISSN
1522-9645
Journal
European Heart Journal
Quellenangaben
Volume: 44,
Issue: 40,
Pages: 4281-4283
Publisher
Oxford University Press
Publishing Place
Great Clarendon St, Oxford Ox2 6dp, England
Reviewing status
Peer reviewed
Institute(s)
Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
POF-Topic(s)
30201 - Metabolic Health
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-506501-001
WOS ID
001077144300001
Scopus ID
85176360303
PubMed ID
37639486
Erfassungsdatum
2023-10-06